Clinical Insight Unlike bronchodilators, PDE-4 inhibitors primarily target inflammation rather than airway smooth muscle, making them useful in reducing COPD exacerbations rather than providing immediate bronchodilation
doi: 10.1093/eurheartj/ehaa160 33
Since it bypasses the digestive tract, its primary weakness (gastric instability) is irrelevant in this context
If youre not a big fan of needles, GHK-Cu is a powerhouse ingredient in lightweight serums and creams marketed for anti-aging
Thymosin beta-4 plays a role in cell migration, blood vessel formation, wound healing, and inflammation control
Orforglipron's unrestricted oral dosing and demonstrated superiority over oral semaglutide in ACHIEVE-3 position it as the preferred oral GLP-1 option for many patients